Abstract
Adenomyosis has only been reported in one patient with mosaic Turner
syndrome. We report a case of mosaic Turner syndrome in a patient who suffered
from hypermenorrhoea and severe anaemia due to adenomyosis. A 40-year-old
woman visited us desiring to conceive. The patient had got pregnant twice, but
they resulted in spontaneous abortion. After her third miscarriage, chromosomal
banding was performed and the patient was found to have a mosaic
chromosome complement (45,X [9]/46,XX [21]). We report an extremely rare
case of a patient with mosaic Turner syndrome who presented with typical
clinical symptoms of adenomyosis.
KKeeyy wwoorrddss:: adenomyosis, dysmenorrhoea, hypermenorrhoea, mosaic Turner
syndrome.
Introduction
Adenomyosis has been reported only in one patient with Turner
syndrome and, in this case, adenomyosis was confirmed in
histopathological examination of a myomectomy specimen [1]. This patient
showed hypermenorrhoea and subsequent severe anaemia. However,
these symptoms were not due to adenomyosis, but to a uterine fibroid.
On the other hand, as for endometriosis, 7 cases of Turner syndrome in
patients having endometriosis have been reported [2]. Thus, it is extremely
rare for Turner syndrome patients to present with symptoms typical of
adenomyosis – namely, an enlarged uterus and secondary dysmenorrhoea.
Natural pregnancies occur in at least 2% of women with Turner
syndrome [3] and, to date, up to 160 spontaneous pregnancies in 74
women have been recorded [4]. Most had a mosaic Turner’s karyotype
containing a 46XX line, although some had non-mosaic Turner syndrome
[5]. We report here adenomyosis in a patient with mosaic Turner syndrome
with a history of severe dysmenorrhoea and three miscarriages.
Case report
The patient, a Japanese woman, presented initially to our hospital at
the age of 40 years; her primary complaint was infertility. Pubertal
development of pubic and axillary hair, secondary sex characteristics, and
breasts were apparently unremarkable. After her menarche at 12 years
of age, the patient experienced regular menstrual cycles at a frequency
of 30 days. Her height was 163 cm and body weight was 54 kg. She had
no abnormal physical findings, including short stature, webbed neck or
Division of Reproductive Medicine, Department of Perinatal Medicine and Maternal
Care, National Center for Child Health and Development, Okura, Setagaya, Tokyo, Japan
SSuubbmmiitttteedd:: 25 July 2007
AAcccceepptteedd:: 10 October 2007
Arch Med Sci 2008; 4, 1: 85–87
Copyright © 2008 Termedia & Banach
CCoorrrreessppoonnddiinngg aauutthhoorr::
Koji Nakagawa, MD, PhD
Division of Reproductive Medicine
Department of Perinatal
Medicine and Maternal Care
National Center for Child Health
and Development
2-10-1 Okura, Setagaya
157-8538, Tokyo, Japan
Phone: +81 3 3416 0181
Fax: +81 3 3416 2222
E-mail:
[email protected]
86 Arch Med Sci 1, March / 2008
shield chest. She has had a regular menstrual cycle
since her menarche. She was nulliparous, as her
prior pregnancies resulted in spontaneous
abortions at 6 and 7 weeks of gestation. After
her third miscarriage, chromosomal banding
was performed. The patient was found to
have a mosaic chromosome complement
(45,X [9]/46,XX [21]) and was diagnosed with
mosaic Turner syndrome.
Gonadotropin levels were normal [follicle-
stimulating hormone (FSH), 7.16 IU/l luteinizing
hormone (LH), 3.12 IU/l]. Cancer antigen-125
(CA-125), which is elevated in association with some
cancers and other benign conditions, such as
endometriosis and adenomyosis, was high
(256 IU/l). Severe iron deficiency anaemia, as
evidenced by a haemoglobin (Hb) concentration
of 8.7 g/dl, was present. Transvaginal ultrasound
examination revealed an enlarged uterus
(145 × 99 × 100 mm) with extreme hypertrophy of
the anterior and posterior uterine walls. In
November 2004, the patient underwent a magnetic
resonance imaging (MRI) scan of the pelvic cavity.
Several findings typical of adenomyosis were
evident as follows: a) enlargement of the uterine
wall with diffusing foci of hyperintensity on the
T2 weighted scans, b) small cystically dilated glands,
c) more acute sites of microhaemorrhages (Figure 1).
The pelvic cavity MRI image of the patient shown in
Figure 1 is characteristic of adenomyosis. Because of
her severe dysmenorrhoea and anaemia, treatment
of the adenomyosis with gonadotropin-releasing
hormone analogue (GnRH-a) was recommended, but
the patient refused treatment with GnRH-a because
of her desire to conceive.
Discussion
Turner syndrome occurs at a frequency of
approximately 50 per 100 000 females, and is the
most frequent common chromosomal aberration
in females. This syndrome is characterized by the
complete or partial absence of one X chromosome.
The most frequent chromosomal constitution is 45X
[6]. About a half of such patients have a mosaic
chromosome component. The most common is
45X/46XX (15%), and 6% of patients have 46XXq or
46XXp deletions. Thus, the syndrome could be the
Result
of a limited amount of genetic material in
these abnormal chromosomes [7].
Turner syndrome is characterized by the physical
finding that often includes congenital lymphedema,
short stature, and gonadal dysgenesis [8]. However,
most patients with mosaic karyotypes have ovaries
with a relatively low number of follicles [9]. There
are some correlations between karyotype and
phenotype [8]. Patients with a karyotype of
45,X/46,XX are the most likely to have spontaneous
menarche and fertility, and they are marginally taller
than other women with Turner syndrome as
a group. Nonetheless, phenotype is unpredictable
based on karyotype only. In our case the patient
had a common mosaic chromosomal complement
in mosaic Turner’s syndrome (45X/46XX). 40% of
them have spontaneous menarche and usually early
ovarian failure, but she had both ovaries with the
normal number of antral follicles by transvaginal
ultrasound examination. She did not show the
typical Turner syndrome in clinical symptoms, but
the rate of 45X cells was 30% and ruled out
common low-level sex chromosome mosaicism
detected in phenotypically normal women.
Only one case of adenomyosis in a patient with
Tuner syndrome who was not receiving long-term
hormone replacement therapy has been reported
[1]. In that report, the patient was a 31-year-old
woman who had been diagnosed with mosaic
Turner syndrome by cytogenetic examination of her
lymphocytes. She had received several cycles of
hormone replacement therapy during adolescence,
but had not received GnRH-agonist treatment.
Because of the patient’s severe anaemia,
a myomectomy was performed, revealing not only
a uterine leiomyoma, but also adenomyosis in the
post-operative histological examination.
In contrast, the patient described in this case report
was a 40-year-old woman who presented with a chief
complaint of infertility. Adenomyosis was not
confirmed histopathologically, but clinical features
and MRI findings, which indicated uterine
enlargement and diffusing foci of hyperintensity on
the T2-weighted scan, were consistent with
adenomyosis. The patient’s chromosomal pattern
was 45X/46XX, which is the most common form
of mosaic Turner syndrome. Adenomyosis is an
Rieko Kojima, Koji Nakagawa, Shirei Ohgi, Takashi Horikawa, Satoshi Kawachiya, Hidekazu Saito
FFiigguurree 11.. T2-weighted midline, sagittal magnetic
resonance image. Findings typical of adenomyosis
are evident: a) enlargement of the uterine wall with
diffusing foci of hyperintensity, b) small cystically
dilated glands, c) more acute sites of
microhaemorrhages. White arrows show small
cystically dilated glands
Arch Med Sci 1, March / 2008 87
oestrogen-dependent disease. If the oestrogenic
condition was maintained, it would cause
oestrogen-dependent disease, such as adenomyosis
and endometriosis, even in patients with mosaic
Turner syndrome. The patient did not have any of the
characteristic physical features of Turner syndrome,
such as short stature, webbed neck and shield chest.
The patient had normal pubertal development of
pubic and axillary hair, secondary sex characteristics
and breast development. After spontaneous
menarche at 12 years of age, the patient had regular
and normal ovulatory menstrual cycles. Surprisingly,
the patient three times became pregnant – at 38, 39
and 40 years of age – but, unfortunately, these
pregnancies ended in miscarriages. Conception is very
rare in patients with mosaic Turner syndrome; among
women with Turner syndrome who become pregnant,
the rates of miscarriages (29%), stillbirths (7%) and
malformation (20%) also are very high [2, 3].
Thus, it appears that the only symptom of
mosaic Turner syndrome exhibited by the patient
described in this report was her miscarriage.
Spontaneous abortion may result from fetal
chromosomal aberrations due to maternal
translocation. From this point of view, the patient
described in this case report would be an ideal
candidate for pre-implantation genetic diagnosis
(PGD). However, in Japan PGD is permitted only for
Duchenne dystrophy and is prohibited by the Japan
Society of Obstetrics and Gynecology for repeated
spontaneous abortions, even though caused by
maternal chromosomal abnormalities. Therefore,
PGD was not performed for this patient.
Because the patient suffered from hyper- and
dysmenorrhoea, resulting in severe anaemia, several
treatment alternatives were recommended,
including a GnRH-agonist, oral contraceptives, or
hysterectomy. However, because of the patient’s
strong desire to conceive none of these treatments
was acceptable.
A strategy for maintaining fecundity in patients
diagnosed with Turner syndrome during
adolescence is needed. For this purpose several
types of assisted reproductive technology, not
oocyte donation and ovarian surrogacy, but, rather,
cryopreservation of ovarian tissue, in vitro
maturation of immature oocytes and ovarian tissue
transplantation techniques are indispensable. In the
near future it will be possible for more patients with
Turner syndrome to bear children.
In conclusion we report an extremely rare case
of a patient with mosaic Turner syndrome who
presented with typical clinical symptoms of
adenomyosis, such as dysmenorrhoea and uterine
enlargement. An alternative condition seems
to be that even though it is extremely rare,
dysmenorrhoea and anaemia may be symptoms of
adenomyosis in women with Turner syndrome.
References
1. Ferrero S, Bentivoglio G. Adenomyosis in a patient with
mosaic Turner’s syndrome. Arch Gynecol Obstet 2005; 271:
249-50.
2. Lazovic G, Spremovic S, Cmiljic I, Vilendacic Z, Milicevic S.
Endometriosis in a woman with mosaic Turner's syndrome:
case report. Int J Fertil Womens Med 2006; 51: 160-2.
3. Hovatta O. Pregnancies in women with Turner's syndrome.
Ann Med 1999; 31: 106-10.
4. Tarani L, Lampariello S, Raguso G, et al. Pregnancy in
patients with Turner's syndrome: six new cases and review
of literature. Gynecol Endocrinol 1998; 12: 83-7.
5. Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben-Rafael Z.
Turner’s syndrome and fertility: current status and possible
putative prospects. Hum Reprod Update 2001; 7: 603-10.
6. Thompson MW, Mclnnes RR, Willard HF . The sex
chromosomal and their abnormalities. In: Thompson MW,
Mclnnes RR, Willard HF (eds). Genetics in Medicine.
Philadelphia: WB Saunders, 1991; 239-43.
7. Turner C, Dennis NR, Skuse DH, Jacobs PA. Seven ring (X)
chromosomes lacking the XIST locus, six with an
unexpectedly mild phenotype. Hum Genet 2001; 106: 93-
100.
8. Virginia PS, McCauley E. Turner's syndrome. N Engl J Med
2004; 351: 1227-38.
9. Novak AZ, Kokai GK, Popovic VP, Ludoski MD, Jurukovski
VA. Interphase cytogenetics on paraffin-embedded sections
of ovary for detection of genomic constitution in a patient
with Turner's syndrome and chromosomal mosaicism. Hum
Genet 1995; 95: 293-8.
Adenomyosis in a patient with mosaic Turner syndrome: case report